Riskpilot← Back to searchSign inGet full accessEVAKSINE AS
ASActiveOrg 921746318Grundingen 2, 0250 OsloOther human health activities n.e.c. · NACE 8699Est. 20182 employees
Revenue 2024
NOK 5,6M
+78% vs 2023
EBITDA margin
-10.3%
-22% vs 2023
Equity ratio
-287.2%
Financial strength
Net profit 2024
NOK -578K
-22% vs 2023
| Revenue | NOK 5,6M | +78% |
| EBITDA | NOK -577K | -22% |
| Net profit | NOK -578K | -22% |
| Total assets | NOK 355K | -29% |
| Equity | NOK -1M | -130% |
| Employees | 2 | — |
Legal name
EVAKSINE AS
Org number
921746318
Legal form
Aksjeselskap
NACE code
8699 · Other human health activities n.e.c.
Founded
26. november 2018
Share capital
NOK 30 000
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Mads grosen istre
Company purpose
Legevirksomhet, virksomhet innen helse, e-helse, ikt, rekruttering, konsulentvirksomhet, medvirkning i andre selskaper, kjøp, salg og forvaltning av aksjer og andeler i andre selskaper, samt alt som hører naturlig til dette.
Address
Grundingen 2, 0250 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 0 | 2 157 | 2 956 | 1 619 | 1 486 | 3 135 | 5 582 |
| Staff expenses | −0 | −20 | −351 | −764 | −338 | −847 | −900 |
| EBITDA | 0 | 753 | 1 559 | −187 | 175 | −472 | −577 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | 0 | 753 | 1 559 | −187 | 175 | −472 | −577 |
| Net financials | 0 | 0 | −1 | −0 | 1 | −1 | −0 |
| Profit before tax | 0 | 753 | 1 558 | −187 | 176 | −473 | −578 |
| Tax | −0 | 166 | 336 | −0 | −0 | −0 | −0 |
| Net profit | 0 | 587 | 1 222 | −187 | 176 | −473 | −578 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Total assets | 30 | 1 167 | 2 393 | 1 691 | 574 | 499 | 355 |
| Equity | 30 | 617 | 1 839 | 1 652 | 30 | −443 | −1 021 |
| Long-term debt | 0 | 0 | 0 | 0 | 402 | 389 | 414 |
| Short-term debt | 0 | 550 | 555 | 39 | 143 | 336 | 962 |
| Total debt | 0 | 550 | 555 | 39 | 544 | 725 | 1 376 |
EBITDA margin
-10.3%
This company
15.8%
Market median
-165% vs market
20182024
Equity ratio
-287.2%
This company
38.2%
Market median
-852% vs market
20182024
Return on equity
-57754100.0%
This company
18.4%
Market median
-313881078% vs market
20182024
Net profit margin
-10.3%
This company
8.1%
Market median
-227% vs market
20182024
Asset turnover
15.71×
This company
1.12×
Market median
+1303% vs market
20182024
Debt / equity
1.35×
This company
0.62×
Market median
-118% vs market
20182024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-09-17 – 2018-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2018 | — | — | |
| Board of Directors | 2023 | — | — | |
| Chairman | 2023 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Upnorth Invest As | Company | 47.5% | 47.5% | 2024 |
Istre Holding As | Company | 25.6% | 25.6% | 2024 |
De Bruycker Holding As | Company | 21.9% | 21.9% | 2024 |
Bjerkholdt Holding As | Company | 5.0% | 5.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
De Bruycker Holding As
EVAKSINE AS Board members of EVAKSINE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Finn Gunnar Strekerud | Chairman | 0 companies |
| Janet Bjørndal Harsem | Board of Directors | 0 companies |
| Mads Grosen Istre | Chairman | 0 companies |